<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04190238</url>
  </required_header>
  <id_info>
    <org_study_id>UniversitateaMFHCJ</org_study_id>
    <nct_id>NCT04190238</nct_id>
  </id_info>
  <brief_title>Efficiency of the Super Inductive System in Spasticity Treatment</brief_title>
  <official_title>Efficiency of the Super Inductive System in Spasticity Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitatea de Medicina si Farmacie Iuliu Hatieganu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitatea de Medicina si Farmacie Iuliu Hatieganu</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to see whether a physical therapy program can relieve pain, decrease
      spasticity and increase muscle contraction force by using the super inductive system (high
      frequency electromagnetic field). It is a longitudinal, prospective study, of 60 patients
      with spasticity after stroke. No new treatment method is tested, as the Super inductive
      system is approved for physical therapy by the Ministry of Health.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The 60 patients will be submitted to 2 treatment groups: 30 patients will receive 10 sessions
      of the superinductive system on the agonist muscles, and 30 patients will receive 10 sessions
      the superinductive system on the agonist and antagonist muscles. All patients will also
      receive the standard kinetotherapy program for spasticity. The patients will be evaluated at
      the beginning of the treatment, at 10 days and at 30 days by using the functional MAS index
      and Barthel index.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 4, 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>case-control study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in MAS functional index</measure>
    <time_frame>day 0, day 10, day 30</time_frame>
    <description>upper extremity functional index</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in Barthel index</measure>
    <time_frame>day 0, day 10, day 30</time_frame>
    <description>measurement of activities of daily living</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Spasticity, Muscle</condition>
  <arm_group>
    <arm_group_label>Spasticity after stroke 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Physical therapy with super inductive system on the agonist and antagonist muscles</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Spasticity after stroke 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Physical therapy with super inductive system on the agonist muscles</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Super inductive system (high frequency electromagnetic field)</intervention_name>
    <description>Super inductive system (high frequency electromagnetic field)</description>
    <arm_group_label>Spasticity after stroke 1</arm_group_label>
    <arm_group_label>Spasticity after stroke 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physical therapy</intervention_name>
    <description>specific for spasticity</description>
    <arm_group_label>Spasticity after stroke 1</arm_group_label>
    <arm_group_label>Spasticity after stroke 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  spasticity after stroke

        Exclusion Criteria:

          -  spasticity of other causes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Viorela M Ciortea, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Medicine and Pharmacy Iuliu Hatieganu</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alina D Ciubean, MD</last_name>
    <phone>0040744635364</phone>
    <email>alina.deniza.ciubean@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinical Rehabilitation Hospital</name>
      <address>
        <city>Cluj-Napoca</city>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Viorela M Ciortea, MD,PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Romania</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 2, 2019</study_first_submitted>
  <study_first_submitted_qc>December 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2019</study_first_posted>
  <last_update_submitted>December 4, 2019</last_update_submitted>
  <last_update_submitted_qc>December 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitatea de Medicina si Farmacie Iuliu Hatieganu</investigator_affiliation>
    <investigator_full_name>Ciubean Alina Deniza</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Spasticity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>if solicited</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>at the end of the study</ipd_time_frame>
    <ipd_access_criteria>on demand by e-mail</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

